Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early visual processing deficits in dysbindin-associated schizophrenia.

Gary Donohoe1, Derek W Morris, Pierfilippo De Sanctis

  • 1Neuropsychiatric Genetics Group, Institute of Molecular Medicine, Trinity College Dublin, St. James Hospital, Dublin, Ireland. donoghug@tcd.ie

Biological Psychiatry
|October 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential deficits in pattern- versus flash-visual evoked potentials in schizophrenia: relationship to subcortical visual systems, pulvinar nucleus and cognition.

Frontiers in neuroimaging·2026
Same author

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Nature genetics·2026
Same author

Serotonin type 3 receptor (5-HT<sub>3</sub>R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Exploration of the genetic neuroinflammatory environment in the human midcingulate cortex in Huntington's disease.

Communications medicine·2026
Same author

The brain network underlying social participation: a multimodal, data-driven investigation.

Brain imaging and behavior·2026
Same author

Opposite sides of different coins: near-diametrical opposition of physiological indices of reduced accuracy of face emotion recognition in schizophrenia and autism spectrum disorders.

Frontiers in neuroimaging·2026
Same journal

Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

Biological psychiatry·2026
Same journal

Remembering Jon-Kar Zubieta, M.D., Ph.D.

Biological psychiatry·2026
Same journal

Kappa opioid receptor availability in borderline personality disorder: An in-vivo investigation with [<sup>11</sup>C]EKAP PET imaging.

Biological psychiatry·2026
Same journal

From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.

Biological psychiatry·2026
Same journal

Distinct and Shared Molecular Mechanisms Underlie Morphological-Functional Overcoupling and Undercoupling in Major Depressive Disorder.

Biological psychiatry·2026
Same journal

Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity.

Biological psychiatry·2026
See all related articles

Schizophrenia risk variants in the dysbindin gene (DTNBP1) are linked to visual processing deficits. Carriers of the dysbindin risk haplotype showed significantly reduced P1 amplitudes, confirming its impact on brain activity.

Area of Science:

  • Neuroscience
  • Psychiatric Genetics

Background:

  • Dysbindin gene (DTNBP1) variations are linked to schizophrenia risk and cognitive deficits.
  • The impact of dysbindin risk variants on sensory processing in schizophrenia is not well understood.
  • Early visual processing deficits, specifically P1 performance, are observed in schizophrenia patients and relatives.

Purpose of the Study:

  • To investigate the relationship between dysbindin risk variants and early visual processing deficits.
  • To examine P1 performance in schizophrenia patients who are carriers versus non-carriers of a known dysbindin risk haplotype.

Main Methods:

  • Measured event-related potential (ERP) responses to visual stimuli using high-density electroencephalography (EEG).
  • Studied 26 individuals diagnosed with schizophrenia (14 risk haplotype carriers, 12 non-carriers).

Related Experiment Videos

Main Results:

  • Schizophrenia patients carrying the dysbindin risk haplotype exhibited significantly reduced P1 amplitudes compared to non-carriers.
  • A large effect size (d = .89) was observed for the difference in P1 amplitude at maximal deficit scalp sites.

Conclusions:

  • These findings provide functional evidence for the detrimental effect of the dysbindin risk haplotype on brain activity.
  • The observed early visual processing deficits, alongside known cognitive impacts, suggest a generalized role for dysbindin in brain function.
  • Dysbindin may play a role in the mechanisms underlying schizophrenia susceptibility.